Cancer clinical trials can exclude those patients most likely to benefit from certain treatments. And institutions usually offer treatments based only on standard protocols. Has cancer medicine become just another industry?
Read about the Randomized Clinical Trial Paradigm:
http://cancerfocus.org/forum/showthread.php?t=3692
World renowned Oncologists are challenging the cancer industry to recognize a Chemo-Screening test (CSRA) that takes the "guesswork" out of drug selection. One of the reasons medical oncologists don’t like in vitro chemosensitivity tests is that it may be in direct competition with the randomized controlled clinical trial paradigm.
http://vimeo.com/72389724